During the past decade, Ear Medical Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ear Medical Group" are "Single Sided Deafness" (3 trials), "AOM - Acute Otitis Media" (2 trials), "Conductive Hearing Loss" (2 trials), "Eustachian Tube Dysfunction" (2 trials) and "OME - Otitis Media With Effusion" (2 trials). Many other conditions were trialed in "Ear Medical Group" in a lesser frequency.

Most popular intervention types in "Ear Medical Group" are "Device" (7 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acclarent Eustachian Tube Balloon Catheter (ETBC)" (1 trials), "Acclarent Tympanostomy Tube Delivery System" (1 trials), "Iontophoresis & tube placement" (1 trials), "Sound amplification provided via the EarLens CHD" (1 trials) and "SoundBite" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ear Medical Group" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ear Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ear Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ear Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".